Molecular Transformer Technology

Stephen Johnston (Inventor)

Research output: Patent

Abstract

Many small molecules of therapeutic interest are rare, difficult/expensive to synthesize or have undesireable biological properties. The system we describe offers a simple, systematic way to convert such small molecules to the biologically equivalent polymer (peptides, DNA, etc.) It could also be used to learn the rules for converting molecular types. This should be faster and require less small molecule that protocols using competition against phage or aptamers. It is also applicable to non-replicating polymers such as peptides.
Original languageEnglish (US)
StatePublished - Jan 30 2006

Fingerprint

Molecules
Polymers
Peptides
Bacteriophages
DNA

Cite this

@misc{0460f8fde2ff4e6c864ac6175d1d0a66,
title = "Molecular Transformer Technology",
abstract = "Many small molecules of therapeutic interest are rare, difficult/expensive to synthesize or have undesireable biological properties. The system we describe offers a simple, systematic way to convert such small molecules to the biologically equivalent polymer (peptides, DNA, etc.) It could also be used to learn the rules for converting molecular types. This should be faster and require less small molecule that protocols using competition against phage or aptamers. It is also applicable to non-replicating polymers such as peptides.",
author = "Stephen Johnston",
year = "2006",
month = "1",
day = "30",
language = "English (US)",
type = "Patent",

}

TY - PAT

T1 - Molecular Transformer Technology

AU - Johnston, Stephen

PY - 2006/1/30

Y1 - 2006/1/30

N2 - Many small molecules of therapeutic interest are rare, difficult/expensive to synthesize or have undesireable biological properties. The system we describe offers a simple, systematic way to convert such small molecules to the biologically equivalent polymer (peptides, DNA, etc.) It could also be used to learn the rules for converting molecular types. This should be faster and require less small molecule that protocols using competition against phage or aptamers. It is also applicable to non-replicating polymers such as peptides.

AB - Many small molecules of therapeutic interest are rare, difficult/expensive to synthesize or have undesireable biological properties. The system we describe offers a simple, systematic way to convert such small molecules to the biologically equivalent polymer (peptides, DNA, etc.) It could also be used to learn the rules for converting molecular types. This should be faster and require less small molecule that protocols using competition against phage or aptamers. It is also applicable to non-replicating polymers such as peptides.

M3 - Patent

ER -